In addition, Yishen capsule was found to ameliorate podocyte injury and delay the progression of DN by regulating the expression of nephrin, podocin, WT-1, α-actinin 4, and podocalyxin in the kidney and podocytes [10, 28,29]. This evidence concerns the gene NPHS1 and liver dysplastic nodule.